Pfizer, Merck Execs Share Emerging Markets Strategies - Windhover's Pharmaceutical Strategic Alliances Conference (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
NEW YORK - Emerging markets will account for almost half of the global pharmaceutical market growth through 2014, according to IMS Health VP Rob Arnold
You may also be interested in...
Merck Confident With Legacy Innovation In Japan And Emerging Markets - JP Morgan Healthcare Conference
TOKYO - Merck has been quite vocal in recent months about shifting its focus to emerging markets, but the company is also expecting big gains in Japan due to a slate of upcoming market launches
Merck Confident With Legacy Innovation In Japan And Emerging Markets - JP Morgan Healthcare Conference
TOKYO - Merck has been quite vocal in recent months about shifting its focus to emerging markets, but the company is also expecting big gains in Japan due to a slate of upcoming market launches
Egyptian Drug Price Reform: New Trade Barrier Or Demand Driver?
The new drug pricing regime, a streamlined registration process and the government's initiative to widen health insurance coverage, could help drive up domestic demand for pharmaceutical products, especially for branded generics.